GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.
Zantac’s Developer Settles Lawsuits Claiming Cancer Link
Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp
Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp
Never miss any important news. Subscribe to our newsletter.
Never miss any important news. Subscribe to our newsletter.
Recent News
Charles Dumont, Who Wrote Enduring Melodies for Édith Piaf, Dies at 95
November 24, 2024
Tony Campolo, Preacher Who Challenged Religious Right, Dies at 89
November 24, 2024
Civil Air Patrol Plane Crashes in Colorado Mountains, Killing Two
November 24, 2024
Rico Carty, Exceptional Hitter Who Was Stymied by Injuries, Dies at 85
November 24, 2024
Does the Conductor Klaus Mäkelä Deserve His Meteoric Rise?
November 24, 2024
Without Drama or Banana, Art Auctions Struggle
November 24, 2024